IDEXX Laboratories, Inc.
IDXX
$556.93
$11.072.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 6.64% | 4.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.64% | 4.61% | |||
| Cost of Revenue | 4.64% | -3.33% | |||
| Gross Profit | 7.80% | 9.82% | |||
| SG&A Expenses | -2.13% | 10.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.64% | 1.60% | |||
| Operating Income | 17.37% | 11.70% | |||
| Income Before Tax | 17.38% | 15.79% | |||
| Income Tax Expenses | 2.36% | 30.96% | |||
| Earnings from Continuing Operations | 21.54% | 12.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.54% | 12.19% | |||
| EBIT | 17.37% | 11.70% | |||
| EBITDA | 16.58% | 10.17% | |||
| EPS Basic | 22.60% | 12.55% | |||
| Normalized Basic EPS | 18.06% | 12.84% | |||
| EPS Diluted | 23.05% | 12.36% | |||
| Normalized Diluted EPS | 18.29% | 12.93% | |||
| Average Basic Shares Outstanding | -0.87% | -0.31% | |||
| Average Diluted Shares Outstanding | -1.06% | -0.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||